Thymosin alpha 1 therapy alleviates organ dysfunction of sepsis patients: a retrospective cohort study

Aim: Thymosin alpha 1 (Tα1) is a promising treatment for the improvement of sepsis patients. Until now, its function in reducing acute organ damage of sepsis patients is still unclear. The aim of this study was to determine whether Tα1 can alleviate organ dysfunction in sepsis patients. Methods: Th...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Fei Pei, Yishan Liu, Lingyun Zuo, Bin Gu, Liqun Liang, Luhao Wang, Yao Nie, Minying Chen, Xiangdong Guan, Jianfeng Wu, on behalf of the China Critical Care Immunotherapy Research Group
Formato: Artigo
Idioma:Inglês
Publicado: Open Exploration Publishing Inc. 2022-04-01
Series:Exploration of Immunology
Assuntos:
immunoparalysis
immunotherapy
thymosin alpha 1
sepsis
sequential organ failure assessment score
Acceso en liña:https://www.explorationpub.com/Journals/ei/Article/100345
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares